Clinical Trial Update: Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing raltitrexed-based vs 5-FU-based neoadjuvant chemotherapy for colorectal liver metastasis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastasis

Drugs mentioned

• 5-FU-based neoadjuvant chemotherapy (5-fluorouracil (5-FU))
• Raltitrexed-based neoadjuvant chemotherapy (Raltitrexed)

Snippet

Sponsor: Zhejiang University | Conditions: Colorectal Cancer, Liver Metastasis | Phase 3 | Status: TERMINATED